Multivariate Cox regression analysis further indicated that positive Gal-9 on TILs (vs negative GAL-9 on TILs; p=0.024, HR 0.436, 95% CI: 0.212–0.897), and SCLC stage I–II (vs SCLC stage III; p=0.014, HR 1.951, 95% CI: 1.146–3.322) were significantly related to better prognosis (table 4). The gene discussed is LGALS9; the disease is small cell lung carcinoma.